Your session is about to expire
← Back to Search
Behavioral Intervention
Acceptance-based Behavioral Therapy (ABBT) Intervention for Substance Use Disorder
N/A
Recruiting
Led By Ethan Moitra, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial will study how well a therapy intervention works to keep people with HIV who use substances in care.
Eligible Conditions
- HIV (Human Immunodeficiency Virus)
- Substance Use Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Client Satisfaction Questionnaire (CSQ)
Secondary outcome measures
Participant Retention Rate Across Intervention Sessions
Participant Retention Rate for Follow Up Assessments
Trial Design
1Treatment groups
Experimental Treatment
Group I: Acceptance-based Behavioral Therapy (ABBT) InterventionExperimental Treatment1 Intervention
All recruited individuals will receive ABBT intervention. ABBT involves 2 sessions delivered within about a week of each other, consisting of a 20-25 minute session 1, and a 10 minute session 2.
Find a Location
Who is running the clinical trial?
Brown UniversityLead Sponsor
452 Previous Clinical Trials
562,163 Total Patients Enrolled
The Miriam HospitalOTHER
237 Previous Clinical Trials
37,190 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,445 Previous Clinical Trials
2,593,961 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Acceptance-based Behavioral Therapy (ABBT) Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger